The 12-item self-rating questionnaire for depressive mixed state (DMX-12) in relation to categorical diagnoses of mixed depression and mixed features-Reference-Cited by-同舟云学术

The 12-item self-rating questionnaire for depressive mixed state (DMX-12) in relation to categorical diagnoses of mixed depression and mixed features

Published:2019-09-09 Issue:0 Volume:10 Page:18-25
ISSN:1884-8826
Container-title:Clinical Neuropsychopharmacology and Therapeutics
language:en
Short-container-title:CNPT

Author:

Shinzato Hotaka¹,Kondo Tsuyoshi¹

Affiliation:

1. Department of Neuropsychiatry, Graduate School of Medicine, University of the Ryukyus

Publisher

The Japanese Society of Clinical Neuropsychopharmacology

Subject

Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical)

Link

https://www.jstage.jst.go.jp/article/cnpt/10/0/10_18/_pdf

Reference22 articles.

1. [1] Fornaro M, Martino M, De Pasquale C, et al. The argument of antidepressant drugs in the treatment of bipolar depression: mixed evidence or mixed states? Expert Opin Pharmacother 2012; 13: 2037-2051.

2. [2] Malhi GS, Lampe L, Coulston CM, et al. Mixed state discrimination A DSM problem that won't go away? J Affect Disord 2014; 158: 8-10.

3. [3] Kondo T, Shinzato H, Koda M. Diagnostic and therapeutic considerations in depressive mixed state. Clin Neuropsychopharmacol Ther 2016; 7: 41-47.

4. [4] Grunze H, Vieta E, Goodwin GM, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Acute and long-term treatment of mixed states in bipolar disorder. World J Biol Psychiatry 2018; 19: 2-58.

5. [5] American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edition, text version (DSM-IV-TR), American Psychiatric Association, Washington, DC, 2000.